FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169244169> ?p ?o ?g. }

• W2169244169 endingPage "528" @default.
• W2169244169 startingPage "521" @default.
• W2169244169 abstract "Statins and bisphosphonates are two distinct classes of isoprenoid pathway inhibitors targeting downstream enzyme to HMG-CoA reductase (upstream enzyme) and farnesyl-pyrophosphate synthase, respectively. Here, we studied fluvastatin (Fluva) and zoledronate (Zol), representative molecules of each class, respectively. In vivo metastatic potentials of both molecules were assessed. For the first time, we observed a significant reduction in progression of established metastases with Fluva treatment. Treatment with both Zol at 100 μg/kg and Fluva at 15 mg/kg inhibited 80% of the metastasis bioluminescence signal and increased survival of mice. The Zol and Fluva transcriptomic profiles of treated MDA-MB-231 cells revealed analogous patterns of affected genes, but each of them reached with different kinetics. The observable changes in gene expression started after 24 h for Fluva IC_{50 72 h} and only after 48 h for Zol IC_{50 72 h}. To obtain early changes in gene expression of Zol-treated cells, a 3 times higher dose of Zol IC_{50 72 h} had to be applied. Combining Fluva and Zol in vivo showed no synergy, but a benefit of several days in survival of mice. This study demonstrated that Zol or Fluva is of potential clinical use for the treatment of established metastasis." @default.
• W2169244169 created "2016-06-24" @default.
• W2169244169 creator A5012713795 @default.
• W2169244169 creator A5023267851 @default.
• W2169244169 creator A5029758858 @default.
• W2169244169 creator A5036525693 @default.
• W2169244169 creator A5048738483 @default.
• W2169244169 creator A5081986749 @default.
• W2169244169 creator A5086006655 @default.
• W2169244169 creator A5089962133 @default.
• W2169244169 date "2012-06-20" @default.
• W2169244169 modified "2023-10-18" @default.
• W2169244169 title "Transcriptome Analysis and In Vivo Activity of Fluvastatin versus Zoledronic Acid in a Murine Breast Cancer Metastasis Model" @default.
• W2169244169 cites W1511853133 @default.
• W2169244169 cites W1947874101 @default.
• W2169244169 cites W1966293734 @default.
• W2169244169 cites W1972665180 @default.
• W2169244169 cites W1989014251 @default.
• W2169244169 cites W1997407159 @default.
• W2169244169 cites W1997591522 @default.
• W2169244169 cites W2002187333 @default.
• W2169244169 cites W2005764975 @default.
• W2169244169 cites W2010779754 @default.
• W2169244169 cites W2020541351 @default.
• W2169244169 cites W2022577155 @default.
• W2169244169 cites W2023934152 @default.
• W2169244169 cites W2041367424 @default.
• W2169244169 cites W2045067033 @default.
• W2169244169 cites W2048748629 @default.
• W2169244169 cites W2054646118 @default.
• W2169244169 cites W2058451329 @default.
• W2169244169 cites W2072318687 @default.
• W2169244169 cites W2077080337 @default.
• W2169244169 cites W2084651782 @default.
• W2169244169 cites W2084865918 @default.
• W2169244169 cites W2099249565 @default.
• W2169244169 cites W2101605510 @default.
• W2169244169 cites W2106712353 @default.
• W2169244169 cites W2113294064 @default.
• W2169244169 cites W2114918609 @default.
• W2169244169 cites W2122513656 @default.
• W2169244169 cites W2152409486 @default.
• W2169244169 cites W2153810797 @default.
• W2169244169 cites W2166119663 @default.
• W2169244169 cites W2170989872 @default.
• W2169244169 cites W2615372951 @default.
• W2169244169 cites W2949951544 @default.
• W2169244169 cites W2951069909 @default.
• W2169244169 doi "https://doi.org/10.1124/mol.111.077248" @default.
• W2169244169 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22723339" @default.
• W2169244169 hasPublicationYear "2012" @default.
• W2169244169 type Work @default.
• W2169244169 sameAs 2169244169 @default.
• W2169244169 citedByCount "10" @default.
• W2169244169 countsByYear W21692441692015 @default.
• W2169244169 countsByYear W21692441692017 @default.
• W2169244169 countsByYear W21692441692018 @default.
• W2169244169 countsByYear W21692441692019 @default.
• W2169244169 countsByYear W21692441692022 @default.
• W2169244169 crossrefType "journal-article" @default.
• W2169244169 hasAuthorship W2169244169A5012713795 @default.
• W2169244169 hasAuthorship W2169244169A5023267851 @default.
• W2169244169 hasAuthorship W2169244169A5029758858 @default.
• W2169244169 hasAuthorship W2169244169A5036525693 @default.
• W2169244169 hasAuthorship W2169244169A5048738483 @default.
• W2169244169 hasAuthorship W2169244169A5081986749 @default.
• W2169244169 hasAuthorship W2169244169A5086006655 @default.
• W2169244169 hasAuthorship W2169244169A5089962133 @default.
• W2169244169 hasConcept C104317684 @default.
• W2169244169 hasConcept C121608353 @default.
• W2169244169 hasConcept C126322002 @default.
• W2169244169 hasConcept C134651460 @default.
• W2169244169 hasConcept C150194340 @default.
• W2169244169 hasConcept C150903083 @default.
• W2169244169 hasConcept C162317418 @default.
• W2169244169 hasConcept C173396325 @default.
• W2169244169 hasConcept C181199279 @default.
• W2169244169 hasConcept C185592680 @default.
• W2169244169 hasConcept C207001950 @default.
• W2169244169 hasConcept C2775933503 @default.
• W2169244169 hasConcept C2776329913 @default.
• W2169244169 hasConcept C2776990775 @default.
• W2169244169 hasConcept C2778417548 @default.
• W2169244169 hasConcept C2779013556 @default.
• W2169244169 hasConcept C2779982574 @default.
• W2169244169 hasConcept C502942594 @default.
• W2169244169 hasConcept C553450214 @default.
• W2169244169 hasConcept C55493867 @default.
• W2169244169 hasConcept C71924100 @default.
• W2169244169 hasConcept C86803240 @default.
• W2169244169 hasConcept C98274493 @default.
• W2169244169 hasConceptScore W2169244169C104317684 @default.
• W2169244169 hasConceptScore W2169244169C121608353 @default.
• W2169244169 hasConceptScore W2169244169C126322002 @default.
• W2169244169 hasConceptScore W2169244169C134651460 @default.
• W2169244169 hasConceptScore W2169244169C150194340 @default.
• W2169244169 hasConceptScore W2169244169C150903083 @default.
• W2169244169 hasConceptScore W2169244169C162317418 @default.

• next